Skip to main content
OpenTrials

Clinical trial condition

VIN3

Explore clinical trials studying VIN3. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

VIN3 trial results

Completed

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

NCT03180684

Conditions
Human Papillomavirus (HPV), Pre-cancerous Lesions of the Vulva, VIN2, +4 more
Locations
  • Christiana Care Health Systems Newark, Delaware, United States
  • Augusta University Augusta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Maine Medical Center Scarborough, Maine, United States
View all 15 locations
View Trial Details

Related conditions